Search Results 341-350 of 17030 for monoclonal antibody

1. Pembrolizumab With or Without Stereotactic Body Radiation Therapy in Treating Patients With Advanced or Metastatic Merkel Cell Cancer - Mayo Clinic

   Monoclonal antibodies, such as pembrolizumab, may interfere with the ability of tumor cells to grow and spread. Stereotactic body radiation therapy is a ...

2. DeeDee Stiepan | Mayo Clinic News Network - Page 17 of 25

   Monoclonal antibody treatment can help high-risk patients with COVID-19. By DeeDee Stiepan • December 4, 2020. Mayo Clinic leader discusses post-Thanksgiving ...

3. A Study to Compare Radiation Therapy + Immune Therapy Treatment (Atezolizumab) for Extensive Stage Small Cell Lung Cancer - Mayo Clinic

   Immunotherapy with monoclonal antibodies, such as atezolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of ...

4. Chronic Myelogenous Leukemia Clinical Trials - Mayo Clinic Research

   Monoclonal antibodies, such as pembrolizumab, may interfere with the ... Phase 1/2 Dose Escalation and Efficacy Study of Anti-CD38 Monoclonal Antibody ...

5. A Study to Evaluate the Addition of Immunotherapy into Adjuvant Therapy for Non-small Cell Lung Cancer - Mayo Clinic

   Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of ...

6. Untitled

   So, before hospitalization, and I'm thinking specifically of monoclonal antibody therapy. Dr. Gregory Poland 16:00. Yes. Dr. Halena Gazelka 16:01. And I ...

7. Mild cognitive impairment - Diagnosis and treatment - Mayo Clinic

   Known as monoclonal antibodies, they include: Lecanemab-irmb (Leqembi). This medicine is given as an IV infusion every two weeks. It can cause infusion ...

8. Wilms Tumor Clinical Trials - Mayo Clinic Research

   Antibody-drug conjugates, such as lorvotuzumab mertansine, are ... Monoclonal antibodies, such as cixutumumab, can block tumor growth in different ways.

9. Study of Rituximab and LMP-Specific T-Cells in Treating Pediatric Solid Organ Recipients With EBV-Positive, CD20-Positive Post-Transplant Lymphoproliferative Disorder - Mayo Clinic

   Monoclonal antibodies, such as rituximab may block tumor growth in different ways by targeting certain cells. LMP-specific T-cells are special immune system ...

10. Hematology - Clinical trials

    Monoclonal antibodies, such as inotuzumab ozogamicin, may block cancer growth in different ways by targeting certain cells. Drugs used in chemotherapy work ...